Michael Stöcker

Title: Michael Stöcker: Innovator in Immunology

Introduction

Michael Stöcker is a prominent inventor based in Aachen, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Stöcker's work focuses on developing novel therapeutic approaches for various diseases.

Latest Patents

Stöcker's latest patents include groundbreaking inventions in the realm of immunokinases. His first patent describes a synthetic, soluble, endogenous complex formed from at least one component A and at least one component B. Component A comprises a binding domain for extracellular surface structures that internalize upon binding, while component B possesses a constitutive catalytic kinase activity. This complex influences cell growth and physiology, making it applicable for treating proliferative diseases, inflammatory diseases, allergies, and autoimmune diseases.

His second patent involves the isolation of allergen-specific immunoglobulin genes from human B-cells of atopy sufferers. This process enables the establishment of comprehensive immunoglobulin-specific reaction profiles by isolating B cells from body fluids, amplifying nucleic acids coding the variable regions of antibodies, and determining the binding capability of recombinant antibodies to antigens.

Career Highlights

Michael Stöcker is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading research organization in Germany. His work at this institution has allowed him to focus on applied research and innovation in immunology.

Collaborations

Stöcker collaborates with notable colleagues, including Stefan Barth and Rainer Fischer. Their combined expertise contributes to advancing research in immunological therapies.

Conclusion

Michael Stöcker's innovative patents and research efforts significantly impact the field of immunology. His work continues to pave the way for new therapeutic strategies to combat various diseases.